Mendel Capital Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
AACR
Mendel Capital Management's JNJ Position: Q2 2026 in Review
Mendel Capital Management reduced its Johnson & Johnson (JNJ) stake by 0.23% in Q2 2026, selling an estimated $4.43K and leaving 8,308 shares worth $2.11M. The position accounts for 0.95% of the portfolio, ranked #21.
Mendel Capital Management first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Mendel Capital Management held 8,308 shares of Johnson & Johnson worth $2.11M as of Q2 2026.
- Mendel Capital Management sold 19 Johnson & Johnson shares in Q2 2026, an estimated $4.43K.
- Johnson & Johnson made up 0.95% of Mendel Capital Management's portfolio in Q2 2026, its #21 holding.
- Mendel Capital Management first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
- 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Mendel Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.